1,1,1-trifluoro-3-(undecylthio)propan-2-one

ID: ALA2289177

Chembl Id: CHEMBL2289177

Cas Number: 92682-27-4

PubChem CID: 185196

Max Phase: Preclinical

Molecular Formula: C14H25F3OS

Molecular Weight: 298.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCSCC(=O)C(F)(F)F

Standard InChI:  InChI=1S/C14H25F3OS/c1-2-3-4-5-6-7-8-9-10-11-19-12-13(18)14(15,16)17/h2-12H2,1H3

Standard InChI Key:  KYDANCUFMCPVOZ-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

PLA2G6 Tchem Calcium-independent phospholipase A2 (359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G4A Tchem Cytosolic phospholipase A2 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.41Molecular Weight (Monoisotopic): 298.1578AlogP: 5.38#Rotatable Bonds: 12
Polar Surface Area: 17.07Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.86CX Basic pKa: CX LogP: 6.18CX LogD: 6.18
Aromatic Rings: Heavy Atoms: 19QED Weighted: 0.45Np Likeness Score: -0.50

References

1. Wheelock CE, Nakagawa Y, Akamatsu M, Hammock BD..  (2003)  Use of classical and 3-D QSAR to examine the hydration state of juvenile hormone esterase inhibitors.,  11  (23): [PMID:14604674] [10.1016/j.bmc.2003.08.023]
2. Mouchlis VD, Morisseau C, Hammock BD, Li S, McCammon JA, Dennis EA..  (2016)  Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A2.,  24  (20): [PMID:27320659] [10.1016/j.bmc.2016.05.009]

Source